These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19851468)

  • 21. Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV.
    Yasui F; Kai C; Kitabatake M; Inoue S; Yoneda M; Yokochi S; Kase R; Sekiguchi S; Morita K; Hishima T; Suzuki H; Karamatsu K; Yasutomi Y; Shida H; Kidokoro M; Mizuno K; Matsushima K; Kohara M
    J Immunol; 2008 Nov; 181(9):6337-48. PubMed ID: 18941225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice.
    Hu H; Lu X; Tao L; Bai B; Zhang Z; Chen Y; Zheng F; Chen J; Chen Z; Wang H
    Clin Vaccine Immunol; 2007 Jul; 14(7):894-901. PubMed ID: 17494640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.
    Frieman MB; Chen J; Morrison TE; Whitmore A; Funkhouser W; Ward JM; Lamirande EW; Roberts A; Heise M; Subbarao K; Baric RS
    PLoS Pathog; 2010 Apr; 6(4):e1000849. PubMed ID: 20386712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection.
    Rockx B; Baas T; Zornetzer GA; Haagmans B; Sheahan T; Frieman M; Dyer MD; Teal TH; Proll S; van den Brand J; Baric R; Katze MG
    J Virol; 2009 Jul; 83(14):7062-74. PubMed ID: 19420084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humoral and cellular immune responses induced by 3a DNA vaccines against severe acute respiratory syndrome (SARS) or SARS-like coronavirus in mice.
    Lu B; Tao L; Wang T; Zheng Z; Li B; Chen Z; Huang Y; Hu Q; Wang H
    Clin Vaccine Immunol; 2009 Jan; 16(1):73-7. PubMed ID: 18987164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice.
    Nagata N; Iwata N; Hasegawa H; Fukushi S; Harashima A; Sato Y; Saijo M; Taguchi F; Morikawa S; Sata T
    Am J Pathol; 2008 Jun; 172(6):1625-37. PubMed ID: 18467696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of interferon-gamma-inducible protein 10 by SARS-CoV infection, interferon alfacon 1 and interferon inducer in human bronchial epithelial Calu-3 cells and BALB/c mice.
    Kumaki Y; Day CW; Bailey KW; Wandersee MK; Wong MH; Madsen JR; Madsen JS; Nelson NM; Hoopes JD; Woolcott JD; McLean TZ; Blatt LM; Salazar AM; Smee DF; Barnard DL
    Antivir Chem Chemother; 2010 Mar; 20(4):169-77. PubMed ID: 20231782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.
    Sheahan T; Morrison TE; Funkhouser W; Uematsu S; Akira S; Baric RS; Heise MT
    PLoS Pathog; 2008 Dec; 4(12):e1000240. PubMed ID: 19079579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells.
    Law HK; Cheung CY; Sia SF; Chan YO; Peiris JS; Lau YL
    BMC Immunol; 2009 Jun; 10():35. PubMed ID: 19505311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease.
    Frieman M; Yount B; Agnihothram S; Page C; Donaldson E; Roberts A; Vogel L; Woodruff B; Scorpio D; Subbarao K; Baric RS
    J Virol; 2012 Jan; 86(2):884-97. PubMed ID: 22072787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alveolar macrophages protect mice from MERS-CoV-induced pneumonia and severe disease.
    Channappanavar R; Selvaraj M; More S; Perlman S
    Vet Pathol; 2022 Jul; 59(4):627-638. PubMed ID: 35499307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.
    Huang J; Cao Y; Du J; Bu X; Ma R; Wu C
    Vaccine; 2007 Sep; 25(39-40):6981-91. PubMed ID: 17709158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential activation of CD8+ T cells in the draining lymph nodes in response to pulmonary virus infection.
    Yoon H; Legge KL; Sung SS; Braciale TJ
    J Immunol; 2007 Jul; 179(1):391-9. PubMed ID: 17579060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection.
    Page C; Goicochea L; Matthews K; Zhang Y; Klover P; Holtzman MJ; Hennighausen L; Frieman M
    J Virol; 2012 Dec; 86(24):13334-49. PubMed ID: 23015710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced induction of SARS-CoV nucleocapsid protein-specific immune response using DNA vaccination followed by adenovirus boosting in BALB/c mice.
    Chunling M; Kun Y; Jian X; Jian Q; Hua S; Minsheng Z
    Intervirology; 2006; 49(5):307-18. PubMed ID: 16809936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS.
    Wang YD; Sin WY; Xu GB; Yang HH; Wong TY; Pang XW; He XY; Zhang HG; Ng JN; Cheng CS; Yu J; Meng L; Yang RF; Lai ST; Guo ZH; Xie Y; Chen WF
    J Virol; 2004 Jun; 78(11):5612-8. PubMed ID: 15140958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice.
    Lu B; Huang Y; Huang L; Li B; Zheng Z; Chen Z; Chen J; Hu Q; Wang H
    Immunology; 2010 Jun; 130(2):254-61. PubMed ID: 20406307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs.
    Ishii K; Hasegawa H; Nagata N; Mizutani T; Morikawa S; Suzuki T; Taguchi F; Tashiro M; Takemori T; Miyamura T; Tsunetsugu-Yokota Y
    Virology; 2006 Aug; 351(2):368-80. PubMed ID: 16678878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
    Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D
    Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice.
    Subbarao K; McAuliffe J; Vogel L; Fahle G; Fischer S; Tatti K; Packard M; Shieh WJ; Zaki S; Murphy B
    J Virol; 2004 Apr; 78(7):3572-7. PubMed ID: 15016880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.